This study also suggests that the detection of CSC markers and mutant p53 by immunohistochemical staining may be effective in therapeutic strategies for lung adenocarcinoma, which indirectly emphasizes the topicality of our study. The gene discussed is TP53; the disease is lung adenocarcinoma.